Understanding corticotropin releasing factor neurobiology: contributions from mutant mice

被引:38
作者
Contarino, A [1 ]
Heinrichs, SC [1 ]
Gold, LH [1 ]
机构
[1] Scripps Res Inst, Dept Neuropharmacol, La Jolla, CA 92037 USA
关键词
D O I
10.1054/npep.1999.0001
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Mice with transgenic expression or deletion of the CRF peptide, transgenic expression of the CRF-BP or deletion of specific CRF receptor subtypes exist and will be valuable for examining candidate mediators in animal model systems recapitulating a variety of normal function. In particular, results described in this review implicate CRF in acute emotional responses studied in animal models of anxiety and drug abstinence. CRF also appears to play a role in behavioral and physiological plasticity judging by alterations in HPA reactivity to stress, information processing and energy balance regulation in CRF mutant models. Accordingly, the creation of genetically engineered mice now permits the evaluation of contributory roles for several CRF-related gene products in the pathophysiology of a variety of complex behavioral disorders. For example, the postulated causal linkage between overactivation of CRF systems and the hyper-emotionality which characterizes human affective disorders can now be more thoroughly evaluated by examining the phenotype of CRF mutant mice in animal models of depression, dementia and substance abuse.
引用
收藏
页码:1 / 12
页数:12
相关论文
共 113 条
  • [51] Corticotropin-releasing factor and glucocorticoid receptor (GR) gene expression in the paraventricular nucleus of immune-challenged transgenic mice expressing Type II GR antisense ribonucleic acid
    Laflamme, N
    Barden, N
    Rivest, S
    [J]. JOURNAL OF MOLECULAR NEUROSCIENCE, 1997, 8 (03) : 165 - 179
  • [52] CHRONIC INFUSION OF A CRH(1) RECEPTOR ANTISENSE OLIGODEOXYNUCLEOTIDE INTO THE CENTRAL NUCLEUS OF THE AMYGDALA REDUCED ANXIETY-RELATED BEHAVIOR IN SOCIALLY DEFEATED RATS
    LIEBSCH, G
    LANDGRAF, R
    GERSTBERGER, R
    PROBST, JC
    WOTJAK, CT
    ENGELMANN, M
    HOLSBOER, F
    MONTKOWSKI, A
    [J]. REGULATORY PEPTIDES, 1995, 59 (02) : 229 - 239
  • [53] CORTICOTROPIN-RELEASING HORMONE-BINDING PROTEIN (CRH-BP) - PLASMA-LEVELS DECREASE DURING THE 3RD TRIMESTER OF NORMAL HUMAN-PREGNANCY
    LINTON, EA
    PERKINS, AV
    WOODS, RJ
    EBEN, F
    WOLFE, CDA
    BEHAN, DP
    POTTER, E
    VALE, WW
    LOWRY, PJ
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1993, 76 (01) : 260 - 262
  • [54] Lovejoy DA, 1998, J NEUROENDOCRINOL, V10, P483
  • [55] A non peptidic corticotropin releasing factor receptor antagonist attenuates fever and exhibits anxiolytic-like activity
    Lundkvist, J
    Chai, Z
    Teheranian, R
    Hasanvan, H
    Bartfai, T
    Jenck, F
    Widmer, U
    Moreau, JL
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1996, 309 (02) : 195 - 200
  • [56] Cortisol levels during human aging predict hippocampal atrophy and memory deficits
    Lupien, SJ
    de Leon, M
    de Santi, S
    Convit, A
    Tarshish, C
    Thakur, M
    McEwen, BS
    Hauger, RL
    Meaney, MJ
    [J]. NATURE NEUROSCIENCE, 1998, 1 (01) : 69 - 73
  • [57] LEARNED HELPLESSNESS - THEORY AND EVIDENCE
    MAIER, SF
    SELIGMAN, MEP
    [J]. JOURNAL OF EXPERIMENTAL PSYCHOLOGY-GENERAL, 1976, 105 (01) : 3 - 46
  • [58] Antidepressant-like effects of CP-154,526, a selective CRF(1) receptor antagonist
    Mansbach, RS
    Brooks, EN
    Chen, YL
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1997, 323 (01) : 21 - 26
  • [59] TRANSGENIC APPROACHES TO COGNITION
    MAYFORD, M
    ABEL, T
    KANDEL, ER
    [J]. CURRENT OPINION IN NEUROBIOLOGY, 1995, 5 (02) : 141 - 148
  • [60] STRESS AND COGNITIVE FUNCTION
    MCEWEN, BS
    SAPOLSKY, RM
    [J]. CURRENT OPINION IN NEUROBIOLOGY, 1995, 5 (02) : 205 - 216